Curemark, LLC, a private, clinical-stage biopharmaceutical company, announced on Thursday that it has named Chris Varelas as its new director.

Varelas serves as a co-founding partner of Riverwood Capital. He has served at Salomon Brothers/Citi as global head of Technology, Media and Telecom Investment banking, head of Citi's National Investment Bank and was a member of Citi's Global Operating Committee. He serves as a trustee of the Aspen Institute.

Dr Joan Fallon, Curemark's CEO and founder, said, 'We are extremely excited to welcome Chris to our board. As Curemark's growth continues to accelerate, his decades of experience in banking, finance and M&A will be invaluable as we navigate the path to commercialisation.'